Informations sur le produit
Nom :
CW069
Description :
CW069 is a pegylated pharmaceutical preparation that has been found to have anti-cancer properties. CW069 has been shown to inhibit the activity of the ubiquitin-proteasome system, which is involved in the degradation of proteins. The drug also inhibits cell division by preventing the assembly of microtubules and disrupting mitosis. CW069 has been shown to be effective against chronic myelogenous leukemia and breast cancer cells, as well as other types of cancer. CW069 may be useful in treating autoimmune diseases such as arthritis or multiple sclerosis because it blocks the inflammatory response by inhibiting neutrophil migration, chemotaxis, and phagocytosis.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
500.33 g/mol
Formule :
C23H21IN2O3
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
